• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down0.56% Nasdaq Down0.79%

    Zogenix, Inc. (ZGNX)

    -NasdaqGM
    9.91 Down 0.37(3.60%) 4:00PM EDT
    ProfileGet Profile for:
    Zogenix, Inc.
    5858 Horton Street
    Suite 455
    Emeryville, CA 94608
    United States - Map
    Phone: 510-550-8300
    Website: http://www.zogenix.com

    Details 
    Index Membership:N/A
    Sector:Healthcare
    Industry:Drug Manufacturers - Major
    Full Time Employees:59

    Business Summary 

    Zogenix, Inc., a pharmaceutical company, develops and commercializes therapies for the treatment of central nervous system disorders in the United States. The company’s lead product candidate is the ZX008, a low-dose fenfluramine for the treatment of seizures associated with Dravet syndrome. It also develops Relday, an injectable formulation of risperidone that is in Phase III clinical trial to treat the symptoms of schizophrenia and bipolar disorder in adults and teenagers with 13 years of age and older. In addition, Zogenix, Inc. provides contract manufacturing services. The company was formerly known as SJ2 Therapeutics, Inc. and changed its name to Zogenix, Inc. in August 2006. Zogenix, Inc. was founded in 2006 and is headquartered in San Diego, California.

    Key Statistics


    Company Websites 
    Home Page
    Search Yahoo! for:
    More on Zogenix, Inc.

    Corporate Governance 
    Zogenix, Inc.’s ISS Governance QuickScore as of May 1, 2016 is 10. The pillar scores are Audit: 5; Board: 6; Shareholder Rights: 8; Compensation: 10.
    Brought to you by Institutional Shareholder Services (ISS)

    Key Executives 
     PayExercised
    Dr. Stephen J. Farr Ph.D., 57
    Co-Founder, Chief Exec. Officer, Pres and Director
    699.00K0.00
    Mr. Roger L. Hawley , 63
    Co-Founder and Director
    775.00K0.00
    Ms. Ann D. Rhoads , 51
    Chief Financial Officer, Principal Accounting Officer, Exec. VP, Treasurer and Sec.
    517.00K0.00
    Dr. Gail M. Farfel Ph.D., 52
    Chief Devel. Officer and Exec. VP
    323.00K0.00
    Dr. Bradley S. Galer M.D., 54
    Chief Medical Officer and Exec. VP
    517.00K0.00
    Amounts are as of Dec 31, 2015 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
    Currency in USD.
    View Insiders